Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. [electronic resource]
Producer: 20081014Description: 1893-900 p. digitalISSN:- 1460-2180
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Caspase 9 -- metabolism
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Female
- GTP-Binding Proteins
- Humans
- Isoxazoles -- pharmacology
- NF-kappa B -- metabolism
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Protein Glutamine gamma Glutamyltransferase 2
- Signal Transduction
- Transglutaminases -- analysis
- X-Linked Inhibitor of Apoptosis Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.